Success Stories in mRNA Vaccine Development

Establishing capacity for manufacturing mRNA therapeutics and vaccines can be complicated, especially when the urgent needs require production readiness.

This whitepaper discusses how public-private collaboration enabled technology development and established the infrastructure for mRNA R&D and production capacity in Africa.

To download this whitepaper, please complete the webform.